Low-income Californians who use GLP-1s for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead.
The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts demonstrate that modest (~10%) NfL reductions are ...
ARLINGTON, MA - January 06, 2026 - PRESSADVANTAGE - Drug testing in Chandler, AZ has shifted from a simple checkbox in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback